http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2568878-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f68c10f3d568ea33807417a9166e1ce1 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-536 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-24 |
| filingDate | 2014-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18ff8e9dd6c23fefeff5a7519d2c705f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcf9853e76f54d00c750bfcffd5b78cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d7f7774e9a6ae429a237d70b54e78f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c89bd9b2ee943dc0eab44d93ef0bec07 |
| publicationDate | 2015-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2568878-C1 |
| titleOfInvention | Method and agent for preventing intra- and postoperative complications in patient with lung cancer and chronic obstructive pulmonary disease |
| abstract | FIELD: medicine. n SUBSTANCE: method involves a perioperative drug therapy. Spiriva® Respimat® is administered in accordance with the following regimen: at the preoperative stage - in a dose of 2.5 mcg 2 inhalations once a day for 2 weeks; on the day of operation - before general anaesthesia and artificial pulmonary ventilation, in a dose of 2.5 mcg 1 inhalation, and during surgical management 1 inhalation in a dose of 2.5 mcg is used in an operated lung directly through a two-lumen intratracheal tube immediately after ventilation is restored; in the postoperative period - in a dose of 2.5 mcg 2 inhalations once a day for 2 weeks. n EFFECT: optimal clinical course of the perioperative period, more effective treatment by reducing a rate of intra- and postoperative bronchopulmonary complications in the above group of patients. n 2 cl, 2 tbl, 1 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2621381-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2684761-C1 |
| priorityDate | 2014-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.